HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,912,000 | -42.3% | 45,855 | -40.9% | 0.01% | -39.1% |
| Q4 2020 | $3,314,000 | +41.3% | 77,578 | -13.1% | 0.02% | +43.8% |
| Q3 2020 | $2,346,000 | -23.2% | 89,278 | -21.6% | 0.02% | -33.3% |
| Q2 2020 | $3,053,000 | +53.7% | 113,878 | +3.2% | 0.02% | +33.3% |
| Q1 2020 | $1,986,000 | -11.2% | 110,378 | -12.5% | 0.02% | +20.0% |
| Q4 2019 | $2,236,000 | -7.8% | 126,078 | -19.4% | 0.02% | 0.0% |
| Q3 2019 | $2,425,000 | -22.8% | 156,378 | -14.4% | 0.02% | -28.6% |
| Q2 2019 | $3,140,000 | +258.9% | 182,778 | +236.3% | 0.02% | +250.0% |
| Q1 2019 | $875,000 | +15.7% | 54,355 | +5.2% | 0.01% | 0.0% |
| Q4 2018 | $756,000 | -35.9% | 51,655 | -20.4% | 0.01% | -33.3% |
| Q3 2018 | $1,179,000 | +60.0% | 64,863 | +48.6% | 0.01% | +80.0% |
| Q2 2018 | $737,000 | -16.2% | 43,663 | -2.7% | 0.01% | 0.0% |
| Q1 2018 | $879,000 | – | 44,863 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |